Fresh off raising $1.8M, Chapel Hill startup preps for $8 million Posted Jan 27, 2017 Chapel Hill-based startup Renovion – which is developing a nebulized therapy called Arina-1 for the treatment of lung transplant patients– has its eyes on submitting a New Drug Application to the U.S. Food and Drug Administration in early 2019, according to chief executive officer Dan Copeland. (Triangle Business Journal)